search
Back to results

Inner Speech and Naming Treatment for Individuals With Aphasia

Primary Purpose

Aphasia, Anomia, Language Disorders

Status
Enrolling by invitation
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Naming treatment
Sponsored by
George Washington University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Aphasia focused on measuring Aphasia, Anomia, Speech-Language Pathology, Speech Therapy, Inner Speech

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Have aphasia resulting from stroke occurring at least 6 months ago Are at least 18 years old Learned English at age 5 years or younger Normal or corrected-to-normal hearing and vision Have access to reliable internet at home for remote participation Exclusion Criteria: Have a history of other brain conditions that could impact interpretation of results (such as Parkinson's Disease or dementia) Have a history of psychiatric disease requiring hospitalization, electroconvulsive therapy, or ongoing medication use (other than common antidepressants)

Sites / Locations

  • The George Washington University

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Naming Treatment

Arm Description

Participants will complete three sessions of baseline probe testing (40 treatment items) occurring virtually on three consecutive days prior to treatment onset. Participants will then complete 10 sessions of therapy scheduled five days a week for two weeks, all occurring virtually. The treatment approach for this study will be a hierarchical, cueing-based treatment for naming.

Outcomes

Primary Outcome Measures

Naming accuracy for sIS vs. uIS items (of 100%)
A direct comparison of treatment response for successful inner speech (sIS) vs. unsuccessful inner speech (uIS) items, measured via accuracy on a spoken naming test.

Secondary Outcome Measures

Overall naming accuracy (of 100%)
A comparison of pre-treatment (average of three baseline sessions) to post-treatment spoken naming (40 items) across participants

Full Information

First Posted
July 21, 2023
Last Updated
July 31, 2023
Sponsor
George Washington University
search

1. Study Identification

Unique Protocol Identification Number
NCT05980897
Brief Title
Inner Speech and Naming Treatment for Individuals With Aphasia
Official Title
Inner Speech and Naming Treatment for Individuals With Aphasia
Study Type
Interventional

2. Study Status

Record Verification Date
July 2023
Overall Recruitment Status
Enrolling by invitation
Study Start Date
July 5, 2023 (Actual)
Primary Completion Date
July 2024 (Anticipated)
Study Completion Date
December 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
George Washington University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
Aphasia is a language disorder, commonly resulting from stroke or other brain injury, that impacts a person's ability to communicate. This project is looking to improve upon current treatment methods for spoken naming in people with aphasia. People with aphasia frequently report being able to successfully say a word in their head, regardless of their ability to say the word out loud. For example, when presented with a picture of a house, they may report being able to think or hear "house" in their head, even if they can't name it out loud. This "little voice" inside one's head is known as inner speech (IS). Previous research suggests that some people with aphasia can re-learn to say words with successful IS (i.e., words they can already say in their heads) easier and faster than words with unsuccessful IS. This study will extend these findings by implementing a comparative treatment study in a larger group of participants with aphasia. The results will help to establish recommendations for speech-language pathologists in choosing treatment stimuli for anomia.
Detailed Description
Aphasia, a language disorder commonly acquired through stroke, has chronic negative impacts on communication abilities and quality of life. The specific language deficits associated with aphasia typically vary from person to person, but a universal element of aphasia is anomia, or difficulty with naming and word-finding. It is well-known that individuals with aphasia struggle to convey their ideas through overt speech, but little is known about this population's ability to access and utilize inner speech (IS). IS can be defined in many ways, but one simple definition that is well known to most language users is the mental imagery of having a little voice in one's head. Importantly, individuals with aphasia often endorse a mismatch between this "little voice" (IS) and what they can actually say out loud. In a prior interview-based study, over 75% of individuals with aphasia endorsed the specific experience of being able to say a word in their head despite being unable to say it aloud. Previous research examined whether self-reported "successful IS" (sIS) (i.e., I can say the word in my head and it sounds right) predicted therapy outcomes in two participants. In both participants, self-reported IS predicted whether or not (and how quickly) individual words were successfully re-learned during a paired-associate treatment for anomia, and the effect was visible within just a few treatment sessions. This trial provides preliminary evidence that IS can be leveraged to improve outcomes of naming therapy for individuals with aphasia. This study aims to extend these prior finding by implementing a behavioral treatment for anomia using a single-subject experimental design in a larger group of individuals with aphasia. The investigators predict that items reported as sIS will be more effectively learned during anomia treatment than items that are reported as uIS. Because sIS items are already being retrieved by the individual, one can think of them as being closer to successful spoken output than items that are not able to be retrieved (i.e., those reported as uIS).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Aphasia, Anomia, Language Disorders, Communication Disorders
Keywords
Aphasia, Anomia, Speech-Language Pathology, Speech Therapy, Inner Speech

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
Alternating treatment single-subject experimental design
Masking
None (Open Label)
Allocation
N/A
Enrollment
10 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Naming Treatment
Arm Type
Experimental
Arm Description
Participants will complete three sessions of baseline probe testing (40 treatment items) occurring virtually on three consecutive days prior to treatment onset. Participants will then complete 10 sessions of therapy scheduled five days a week for two weeks, all occurring virtually. The treatment approach for this study will be a hierarchical, cueing-based treatment for naming.
Intervention Type
Behavioral
Intervention Name(s)
Naming treatment
Intervention Description
In this alternating treatment single-subject experimental design study, the investigators will alternate between two treatment conditions, i.e., two different types of stimulus items: those that are consistently reported as successful IS prior to treatment (sIS items) and those that are consistently reported as unsuccessful IS prior to treatment (uIS items). The treatment will be computerized to ensure consistency of presentation, timing, and cues across participants. For each stimulus presentation, the treatment hierarchy will proceed as follows: Name the picture independently Name the picture with a written cue Repeat the name of the picture Name the picture after a 5 second delay Each participant will be trained on a set of 40 items chosen specifically for them based on initial/baseline testing.
Primary Outcome Measure Information:
Title
Naming accuracy for sIS vs. uIS items (of 100%)
Description
A direct comparison of treatment response for successful inner speech (sIS) vs. unsuccessful inner speech (uIS) items, measured via accuracy on a spoken naming test.
Time Frame
5 weeks
Secondary Outcome Measure Information:
Title
Overall naming accuracy (of 100%)
Description
A comparison of pre-treatment (average of three baseline sessions) to post-treatment spoken naming (40 items) across participants
Time Frame
5 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Have aphasia resulting from stroke occurring at least 6 months ago Are at least 18 years old Learned English at age 5 years or younger Normal or corrected-to-normal hearing and vision Have access to reliable internet at home for remote participation Exclusion Criteria: Have a history of other brain conditions that could impact interpretation of results (such as Parkinson's Disease or dementia) Have a history of psychiatric disease requiring hospitalization, electroconvulsive therapy, or ongoing medication use (other than common antidepressants)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Mackenzie Fama
Organizational Affiliation
The George Washington University
Official's Role
Principal Investigator
Facility Information:
Facility Name
The George Washington University
City
Washington
State/Province
District of Columbia
ZIP/Postal Code
20052
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
Investigators will share de-identified data and/or testing materials with interested researchers, educators or clinicians upon request.
IPD Sharing Time Frame
Data will be made accessible at the time of initial publication.
IPD Sharing Access Criteria
Access to participant data by an external researcher may require a formal data sharing agreement with that researcher's institution.
Citations:
PubMed Identifier
27694017
Citation
Fama ME, Hayward W, Snider SF, Friedman RB, Turkeltaub PE. Subjective experience of inner speech in aphasia: Preliminary behavioral relationships and neural correlates. Brain Lang. 2017 Jan;164:32-42. doi: 10.1016/j.bandl.2016.09.009. Epub 2016 Sep 29.
Results Reference
background
PubMed Identifier
30950758
Citation
Fama ME, Snider SF, Henderson MP, Hayward W, Friedman RB, Turkeltaub PE. The Subjective Experience of Inner Speech in Aphasia Is a Meaningful Reflection of Lexical Retrieval. J Speech Lang Hear Res. 2019 Jan 30;62(1):106-122. doi: 10.1044/2018_JSLHR-L-18-0222.
Results Reference
background
PubMed Identifier
30921682
Citation
Fama ME, Henderson MP, Snider SF, Hayward W, Friedman RB, Turkeltaub PE. Self-reported inner speech relates to phonological retrieval ability in people with aphasia. Conscious Cogn. 2019 May;71:18-29. doi: 10.1016/j.concog.2019.03.005. Epub 2019 Mar 25.
Results Reference
background
PubMed Identifier
31518502
Citation
Fama ME, Turkeltaub PE. Inner Speech in Aphasia: Current Evidence, Clinical Implications, and Future Directions. Am J Speech Lang Pathol. 2020 Feb 21;29(1S):560-573. doi: 10.1044/2019_AJSLP-CAC48-18-0212. Epub 2019 Sep 13.
Results Reference
background
PubMed Identifier
27469037
Citation
Hayward W, Snider SF, Luta G, Friedman RB, Turkeltaub PE. Objective support for subjective reports of successful inner speech in two people with aphasia. Cogn Neuropsychol. 2016 Jul-Sep;33(5-6):299-314. doi: 10.1080/02643294.2016.1192998. Epub 2016 Jul 29.
Results Reference
background

Learn more about this trial

Inner Speech and Naming Treatment for Individuals With Aphasia

We'll reach out to this number within 24 hrs